The High Court heard arguments regarding whether a substantial portion of a multi-million-pound concussion litigation case should be dismissed. Players from rugby union and rugby league have filed claims asserting that sport authorities failed to implement adequate protections against repeated head impacts. The governing bodies named as defendants—World Rugby, the Welsh Rugby Union, the Rugby Football Union, and the Rugby Football League—maintain they did not breach their duty of care obligations.
During proceedings on Wednesday, legal representatives for the governing bodies contended that numerous claims warrant dismissal based on alleged non-compliance with a 2024 court order. Specifically, they argued that documents related to neurological testing procedures were not properly disclosed. The rugby league bodies’ counsel characterized the non-compliance as “systemic and without good reason,” while World Rugby’s representatives described dismissal as a last-resort measure made necessary by continued non-cooperation with court directives. The bodies sought dismissal of 132 claims against the rugby league defendants and 378 claims against the rugby union defendants.
The players’ legal counsel disputed this characterization, arguing in written submissions that any breaches were neither serious nor significant given the extensive documentary nature of the complex litigation. They characterized claim dismissal as an extreme procedural response and emphasized the case’s substantial public interest, noting its significance for the future of contact and collision sports in the UK.
A separate development emerged when Richard Boardman, the solicitor representing the claimants, indicated his intention to cease representation. The judge expressed frustration with the litigation’s pace, describing the parties as “passengers” in the process. Following the hearing, one of the high-profile claimants issued a statement thanking the departing solicitors but indicating that new representation was necessary given the case’s scale and complexity, with hope that the change would accelerate proceedings.
Several prominent former players are involved in the action, which commenced in 2020. The case continues with disputes over medical information sharing persisting throughout the litigation.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI